| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |